Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 2/20 | 0.34 |
| ▸ | JAK3 | P52333 | 2/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | BDKRB1 | P46663 | 5/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.33 |
| ▸ | MPL | P40238 | 2/20 | 0.33 |
| ▸ | BRAF | P15056 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.31 |
| ▸ | LCK | P06239 | 2/20 | 0.31 |
| ▸ | KIT | P10721 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2811232 | 0.92 | BRAF (0.36) | BDKRB1MPLBRAFHDAC3HDAC1 | |
| SCHEMBL2806523 | 0.92 | BDKRB1 (0.33) | JAK1JAK3JAK2BDKRB1PDE10A | |
| SCHEMBL186120 | 0.90 | JAK1 (0.34) | JAK1JAK3JAK2PDE10AMPL | |
| SCHEMBL2804889 | 0.87 | MAPK9 (0.36) | JAK3JAK2BDKRB1BRAFHDAC3 | |
| SCHEMBL2805105 | 0.84 | BDKRB1 (0.34) | BDKRB1PDE10ABRAFHDAC3HDAC1 | |
| SCHEMBL2805743 | 0.84 | BDKRB1 (0.34) | BDKRB1PDE10ABRAFHDAC3HDAC1 | |
| SCHEMBL185363 | 0.82 | FAAH (0.31) | JAK1JAK3JAK2PTGS2MAP4K1 | |
| SCHEMBL186646 | 0.82 | L3MBTL1 (0.35) | BRAFLCK | |
| SCHEMBL2806524 | 0.82 | BRAF (0.38) | BDKRB1PDE10ABRAFLCKKIT | |
| SCHEMBL2805107 | 0.82 | BDKRB1 (0.42) | JAK1JAK3JAK2BDKRB1PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068439-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA North aAmerica S.ar.I (US) | 2010-03-18 | — | — | US | claimed |
| WO-2008095071-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA TECHNOLOGIES S.AR.L. (CH) | 2008-08-07 | — | — | WO | claimed |
| EP-3260920-A1 | TONER COMPOSITIONS WITH ANTIPLASTICIZERS | Xerox Corporation (US) | 2017-12-27 | — | — | EP | disclosed |
| US-9684257-B1 | Toner compositions with antiplasticizers | XEROX CORPORATION (US) | 2017-06-20 | — | — | US | disclosed |
| US-20100240669-A1 | NEW COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-23 | — | — | US | disclosed |
| US-20100068439-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA North aAmerica S.ar.I (US) | 2010-03-18 | — | — | US | disclosed |
| WO-2008095071-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA TECHNOLOGIES S.AR.L. (CH) | 2008-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240669-A1 | NEW COMPOUNDS | ADORA1, H1-10, P2RY11 | JAK1 936/4885JAK3 2297/4885JAK2 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.